首页> 外国专利> SYSTEM FOR EVALUATING PROFITABILITY OF MEDICAL DRUG CANDIDATE UNDER DEVELOPMENT

SYSTEM FOR EVALUATING PROFITABILITY OF MEDICAL DRUG CANDIDATE UNDER DEVELOPMENT

机译:开发中的医用药候选资格评估系统

摘要

A system (10) for evaluating the profitability of a developed medicine has adata set creating subsystem (100) and a management index calculating subsystem(200). The data set creating subsystem includes a sales total predicting unit(110), an expense predicting unit (120), a net present value (NPV) calculatingsection (131), an internal rate-of-return (IRR) calculating unit (140), arepetitively calculating unit (150), for creating a data set in which thevalues calculated by the predicting units and calculating units are variedwithin a predetermined distribution width, and a data set recording unit(160). The management index calculating subsystem includes a volatilitycalculating unit (201), an option value calculating unit (202), and a projectvalue calculating unit (203). Thus, the system evaluates the investmentprofitability of the research and development of a medicine by using a realoption method.
机译:用于评估已开发药品的获利能力的系统(10)具有数据集创建子系统(100)和管理指标计算子系统(200)。数据集创建子系统包括销售总额预测单元(110),费用预测单元(120),净现值(NPV)计算部分(131),内部收益率(IRR)计算单元(140),重复计算单元(150),用于创建数据集,其中由预测单元和计算单元计算出的值是变化的在预定分布宽度内,以及数据集记录单元(160)。管理指标计算子系统包括波动性计算单元(201),选项值计算单元(202)和项目值计算单元(203)。因此,系统评估投资通过使用真实的药物进行研究和开发的盈利能力选择方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号